ITV

Tag: Sanofi

  • Combiflam ICYHOT takes on ‘strong pain’ in new campaign by Ogilvy

    Combiflam ICYHOT takes on ‘strong pain’ in new campaign by Ogilvy

    MUMBAI: Sanofi India – makers of the Combiflam range – has launched the latest ad campaign for its topical analgesic Combiflam ICYHOT.  The ad film has been conceptualised by Ogilvy and drives the ‘Strong pain ko do strong jawab’ message of the brand. The campaign will have a 360 degree approach including TV, digital and on-ground activation.

    As per the brand, the campaign is a clutter-breaking ad with humorous undertones that is bringing smiles on the face of viewers. The ad film was developed on the insight that pain can weigh one down and can derail one’s day to day life. Effective respite from pain can help people get back on track and move forward.

    Sanofi general manager – consumer healthcare, India and South Asia Nikhilesh Kalra said, “We understand how everyday pain affects the quality of life. No matter how much care one takes, physical pain of some sort will find its way to us. Strong pain needs an effective pain relief solution. Combiflam ICYHOT is a topical pain reliever available in gel and spray format for instant and long lasting relief to people suffering from muscle pains and sprains. Given the clutter in the pain segment, our ad is distinctive and hence, memorable, delivering the brand message and the product benefits in an engaging manner.”

    Ogilvy group creative director Srreram Athray said, “The Combiflam ICYHOT film is a quirky take on the pain we may suffer in our everyday lives that end up robbing us of vigour. We tried to deliver the brand message in a way that would resonate with most Indians, in a way never tried before within the category.”

    Ogilvy group creative director Elizabeth Dias added, “The overall look and feel, personification of the characters – strong pain, icy and hot, the hip music lends a really positive vibe to the film and would surely bring a smile to your face.”

  • Combiflam tablet launches pain education campaign for rural marke

    Combiflam tablet launches pain education campaign for rural marke

    MUMBAI: Sanofi India – makers of the Combiflam pain relief tablets along with Bollywood actor Soha Ali Khan has launched its first initiative under its pain education campaign – Pain Clinics.

    This phase comprises a series of doctor and pain expert videos on a dedicated YouTube channel to generate awareness and educate people, so that they can understand and treat pain in an informed and responsible manner.

    The subsequent phases of the campaign will include multi-channel awareness drives and data-driven insights rolled out across the country to help people understand and manage pain effectively.

    According to a survey conducted by IPSOS in India, every person admitted to suffering from some kind of pain in the last 12 months, and 43 per cent of the pain occasions were treated with an available painkiller at home. This shows the need for an initiative that brings national pain management experts and doctors on board, to provide tips and advice on how pain can be better managed.

    Sanofi GM of consumer healthcare, India and South Asia Nikhilesh Kalra says, “Combiflam tablet is India’s most prescribed pain relief brand and relieves over 1.8 billion pain incidences in a year4. It is the trusted household name for millions of people and healthcare practitioners. It is common for people to seek health related information on internet. However, not all information one finds on the web is credible, and hence, we felt the need to launch a credible source of information.”

    “Uttar Pradesh has some of the highest pain incidences in the country, and an average of 15 lakh incidences of pain are resolved by the Combiflam every day. This is why Uttar Pradesh is a very important State for us, and a social initiative such as this one will be of great value. We are launching this initiative in Uttar Pradesh and plan to scale it across the country”, adds Kalra.

    Arthroscopy and sports injury specialist Dr. Moazzam Jah adds, “It is common for people to trust the internet for information and solutions, for their pain. This is dangerous and misleading, and we as doctors, strongly advocate that patients speak to us or ensure they consume information that is not only validated, but also medically correct. Combiflam® tablet has also been a victim of some misleading social media messages in the past that have questioned its safety and efficacy.”

    Sanofi India Ltd. is launching this social initiative in seven cities of Uttar Pradesh – Lucknow, Kanpur, Allahabad, Gorakhpur, Moradabad, Varanasi and Bareilly.